Before taking Emflaza(Deflazacort)

This part details important safety information and conditions requiring special attention during treatment.

Important Safety Information

Caution is advised due to numerous potential risks. EMFLAZA can cause hypothalamic-pituitary-adrenal axis suppression, hyperglycemia, and Cushing's syndrome. It suppresses the immune system, increasing susceptibility to infections and reactivating latent ones. Patients should be monitored for hypertension, electrolyte imbalances, and gastrointestinal issues. Behavioral and mood disturbances, as well as negative effects on bone health and growth in children, are significant concerns that require monitoring.

Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved